Mechanisms underlying sensitivity to organophosphorus anticholinesterase compounds.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001812:Blood-Brain Barrier / Q000187:drug effects; D002799:Cholinergic Fibers / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D002801:Cholinesterase Reactivators / Q000378:metabolism / Q000494:pharmacology; D004361:Drug Tolerance; D018377:Neurotransmitter Agents / Q000378:metabolism; D009943:Organophosphorus Compounds / Q000378:metabolism / Q000494:pharmacology*; D011976:Receptors, Muscarinic / Q000187:drug effects; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators; D018377:Neurotransmitter Agents; D009943:Organophosphorus Compounds; D011976:Receptors, Muscarinic; D000109:Acetylcholine